Capital World Investors
DCOY

Capital World Investors’s Decoy Therapeutics DCOY Stock Holding History

Capital World Investors’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Hold
0
– -$4.45M – 518
2015
Q4 		– Sell
-1
Closed -$10.5M – 501
2015
Q3 		$6.22M Buy
+1
New +$13M ﹤0.01% 496
2015
Q2 		– Hold
0
– – – 510
2015
Q1 		– Hold
0
– – – 503

Other funds holding DCOY

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors's DCOY Position: Q1 2016 in Review

Capital World Investors held its Decoy Therapeutics (DCOY) position steady in Q1 2016 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Capital World Investors first reported a position in DCOY in Q3 2015 and has held it in 1 quarter since. The position peaked at $6.22M in Q3 2015. 4 funds tracked by Wall St. Rank hold DCOY as of Q1 2016.

  • Capital World Investors held 0 shares of Decoy Therapeutics worth $0 as of Q1 2016.
  • Capital World Investors left its Decoy Therapeutics share count unchanged in Q1 2016.
  • Decoy Therapeutics made up ﹤0.01% of Capital World Investors's portfolio in Q1 2016, its #518 holding.
  • Capital World Investors first reported a position in Decoy Therapeutics in Q3 2015 and has held it in 1 quarter since.
  • Capital World Investors's Decoy Therapeutics position peaked at $6.22M in Q3 2015.
  • 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q1 2016.

Based on Capital World Investors's 13F filing for Q1 2016, filed 16 May 2016.